Early Risk Factors for Pregnancy Loss in Lupus
- 1 February 2006
- journal article
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 107 (2, Part 1) , 293-299
- https://doi.org/10.1097/01.aog.0000194205.95870.86
Abstract
To identify early risk factors for pregnancy loss in lupus pregnancies. We conducted a cohort study of all pregnancies seen in the first trimester in lupus patients followed from 1987 to 2002 at the Hopkins Lupus Center. At each visit, vital signs, a complete blood count, a urinalysis, and a 24-hour urine collection for total protein, if the dipstick revealed proteinuria, were obtained. Proteinuria was defined as protein greater than 500 mg in a 24-hour urine collection. Secondary antiphospholipid syndrome was diagnosed by using the Sapporo criteria. Thrombocytopenia was defined as platelets under 150,000. Hypertension was defined as blood pressure over 140/90 mm Hg during the first trimester. Pregnancies electively terminated were excluded from this study. One hundred sixty-six pregnancies in 125 women were followed in the Hopkins Lupus Cohort from the first trimester onward. Twenty-seven pregnancies (16%) ended with a loss. Pregnancy loss was increased 2.6 times in women with first-trimester proteinuria (P = .04). A diagnosis of secondary antiphospholipid syndrome led to a 3.1-fold increase in pregnancy loss, predominantly after 20 weeks of gestation (P = .004). Thrombocytopenia in the first trimester led to an increase in pregnancy loss by 3.3 fold (P < or = .001). First-trimester hypertension led to a 2.4-fold increase in pregnancy loss (P = .027). Each risk factor was independent in raising pregnancy loss risk. The acronym PATH can help remind clinicians to monitor for Proteinuria, Antiphospholipid syndrome, Thrombocytopenia, and Hypertension early in pregnancy. Close observation, with frequent laboratory analysis and appropriate therapy, is important to pregnancy success in women with lupus. II-2.Keywords
This publication has 31 references indexed in Scilit:
- The impact of increased lupus activity on obstetric outcomesArthritis & Rheumatism, 2005
- Risks to the children born to mothers with autoimmune diseasesLupus, 2002
- Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnanciesRheumatology, 2002
- International classification criteria for antiphospholipid syndrome: synopsis of a post-conference workshop held at the Ninth International (Tours) aPL SymposiumLupus, 2001
- Pregnancy outcomes in women with systemic lupus erythematosusThe Journal of Maternal-Fetal & Neonatal Medicine, 2001
- Outcome of lupus pregnancy: a controlled studyRheumatology, 2000
- High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodiesHuman Reproduction, 1995
- Antiphospholipid antibody and antiphospholipid antibody syndromeCurrent Opinion in Rheumatology, 1991
- Pregnancy in Lupus Nephritis and Related DisordersAmerican Journal of Kidney Diseases, 1987
- Thrombosis, abortion, cerebral disease, and the lupus anticoagulant.BMJ, 1983